Business Context and Reporting Period
CAMTEK LTD. (NASDAQ: CAMT) is an Israeli company providing automated solutions for the Semiconductors, Printed Circuit Boards (PCB), and IC Substrates industries. This Form 6-K filing, dated August 8, 2013, reports financial results for the quarter ended June 30, 2013 (Second Quarter 2013).
Key Financial Metrics
| Metric | Q2 2013 (GAAP) | Q2 2013 (Non-GAAP) |
|---|---|---|
| Revenues | $22.3 million | $22.3 million |
| Gross Profit | $9.8 million (44.0%) | $9.9 million (44.4%) |
| Operating Income | $1.0 million (4.5%) | $1.2 million (5.4%) |
| Net Income | $0.3 million ($0.01/share) | $1.0 million ($0.03/share) |
| Operating Cash Flow | $1.1 million | $1.1 million |
| Cash & Equivalents (Net of Loans) | $17.6 million | $17.6 million |
Material Changes vs. Prior Periods
- Sequential Growth (vs. Q1 2013): Revenues increased 23% to $22.3 million from $18.1 million. The company returned to profitability, with GAAP operating income of $1.0 million compared to an operating loss of $0.2 million in the prior quarter.
- Year-Over-Year Decline (vs. Q2 2012): Revenues decreased 11% from $25.0 million. GAAP operating income fell to $1.0 million from $3.3 million, and GAAP net income dropped to $0.3 million from $2.3 million.
- Balance Sheet: Net cash position improved slightly to $17.6 million from $17.3 million in Q1 2013, despite the company using $3.1 million of cash to repay bank loans during the quarter.
Guidance, Outlook, and Management Commentary
CEO Roy Porat attributed Q2 revenue growth to the Xact sample preparation product. However, management noted a "pause" in the industry with some order push-outs, similar to peers. While the general atmosphere remains cautious but positive, the company expects sequential revenue decline in the third quarter.
- Q3 2013 Guidance: Revenues are expected to be slightly lower sequentially, in the range of $19 million to $21 million.
- Outlook: Management anticipates growth in the latter part of 2013 and into 2014, citing the company's positioning in cyclical markets with both legacy inspection products and new offerings.
- Risks: The filing highlights standard risks including changing industry trends, reduced demand, competition, and intellectual property litigation.
Investor Verification Checklist
- Verify the sequential revenue decline guidance for Q3 2013 ($19-21 million) against current market conditions.
- Confirm the impact of the $3.1 million bank loan repayment on future liquidity and debt covenants.
- Review the reconciliation of Non-GAAP measures, specifically the exclusion of acquisition-related expenses and share-based compensation.
- Monitor the "pause" in orders mentioned by management and its potential duration into the second half of the year.